Latest News

View All Recent News »

Alimera Sciences to Host Analyst and Investor Luncheon on Wednesday, March 25, 2015 in New York City

March 19, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it will host an Analyst and Investor Luncheon on...

Read More »

Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results

March 04, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the fourth quarter and year ended...

Read More »

Alimera Sciences To Release Fourth Quarter And Fiscal Year 2014 Financial Results

February 23, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its fourth quarter and fiscal year...

Read More »